|
84
|
277
|
3f3wA |
Drug resistant csrc kinase domain in complex with inhibitor rl45 (type ii) |
|
81
|
277
|
3f3vA |
Kinase domain of csrc in complex with inhibitor rl45 (type ii) |
|
6
|
57
|
3fj5A |
Crystal structure of the c-src-sh3 domain |
|
80
|
277
|
3f3tA |
Kinase domain of csrc in complex with inhibitor rl38 (type iii) |
|
73
|
273
|
3et7A |
Crystal structure of pyk2 complexed with pf-2318841 |
|
85
|
276
|
3eqrA |
Crystal structure of ack1 with compound t74 |
|
96
|
290
|
3eyhA |
Crystal structures of jak1 and jak2 inhibitor complexes |
|
91
|
290
|
3eygA |
Crystal structures of jak1 and jak2 inhibitor complexes |
|
77
|
276
|
3en4A |
Targeted polypharmacology: crystal structure of the c-src kinase domain in complex with pp121, a multitargeted kinase inhibitor |
|
83
|
274
|
3eqpA |
Crystal structure of ack1 with compound t95 |
|
70
|
278
|
3en7A |
Targeted polypharmacology: crystal structure of the c-src kinase domain in complex with s1, a multitargeted kinase inhibitor |
|
78
|
276
|
3el8A |
Crystal structure of c-src in complex with pyrazolopyrimidine 5 |
|
14
|
63
|
3eg2A |
Crystal structure of the n114q mutant of abl-sh3 domain |
|
72
|
274
|
3en5A |
Targeted polypharmacology: crystal structure of the c-src kinase domain in complex with pp494, a multitargeted kinase inhibitor |
|
22
|
101
|
3eacA |
Crystal structure of sh2 domain of human csk (carboxyl-terminal src kinase), oxidized form. |
|
71
|
274
|
3en6A |
Targeted polypharmacology: crystal structure of the c-src kinase domain in complex with pp102, a multitargeted kinase inhibitor |
|
12
|
63
|
3eg3A |
Crystal structure of the n114a mutant of abl-sh3 domain |
|
11
|
58
|
3eg1A |
Crystal structure of the n114q mutant of abl-sh3 domain complexed with a designed high-affinity peptide ligand: implications for sh3-ligand interactions |
|
68
|
277
|
3el7A |
Crystal structure of c-src in complex with pyrazolopyrimidine 3 |
|
12
|
56
|
3eg0A |
Crystal structure of the n114t mutant of abl-sh3 domain |
|
81
|
267
|
3emgA |
Discovery and sar of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (syk) |
|
10
|
57
|
3eguA |
Crystal structure of the n114a mutant of abl-sh3 domain |
|
25
|
102
|
3eazA |
Crystal structure of sh2 domain of human csk (carboxyl-terminal src kinase), c122s mutant. |
|
99
|
293
|
3e62A |
Fragment based discovery of jak-2 inhibitors |
|
101
|
293
|
3e64A |
Fragment based discovery of jak-2 inhibitors |
|
99
|
292
|
3e63A |
Fragment based discovery of jak-2 inhibitors |
|
85
|
279
|
3dqwA |
C-src kinase domain thr338ile mutant in complex with atpgs |
|
89
|
270
|
3dk7A |
Crystal structure of mutant abl kinase domain in complex with small molecule fragment |
|
78
|
275
|
3dqxA |
Chicken c-src kinase domain in complex with atpgs |
|
87
|
270
|
3dk3A |
Crystal structure of mutant abl kinase domain in complex with small molecule fragment |
|
84
|
270
|
3dk6A |
Crystal structure of mutant abl kinase domain in complex with small molecule fragment |
|
73
|
263
|
3d7uA |
Structural basis for the recognition of c-src by its inactivator csk |
|
72
|
276
|
3d7tB |
Structural basis for the recognition of c-src by its inactivator csk |
|
61
|
263
|
3d7tA |
Structural basis for the recognition of c-src by its inactivator csk |
|
63
|
277
|
3d7uB |
Structural basis for the recognition of c-src by its inactivator csk |
|
71
|
266
|
3cioA |
The kinase domain of escherichia coli tyrosine kinase etk |
|
12
|
58
|
3cqtA |
N53i v55l mutant of fyn sh3 domain |
|
85
|
268
|
3cs9A |
Human abl kinase in complex with nilotinib |
|
83
|
281
|
3cr0A |
Wee1 kinase complex with inhibitor pd259_809 |
|
83
|
278
|
3cqeA |
Wee1 kinase complex with inhibitor pd074291 |
|
114
|
376
|
3cblA |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes) in complex with staurosporine and a consensus peptide |
|
91
|
276
|
3bz3A |
Crystal structure analysis of focal adhesion kinase with a methanesulfonamide diaminopyrimidine inhibitor |
|
95
|
278
|
3cc6A |
Crystal structure of kinase domain of protein tyrosine kinase 2 beta (ptk2b) |
|
90
|
272
|
3bymA |
X-ray co-crystal structure aminobenzimidazole triazine 1 bound to lck |
|
104
|
376
|
3cd3A |
Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-fes) in complex with staurosporine and a consensus peptide |
|
82
|
272
|
3bysA |
Co-crystal structure of lck and aminopyrimidine amide 10b |
|
114
|
373
|
3bkbA |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes) |
|
84
|
271
|
3byoA |
X-ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6h)-one 25 bound to lck |
|
77
|
271
|
3byuA |
Co-crystal structure of lck and aminopyrimidine reverse amide 23 |
|
88
|
278
|
3bi6A |
Wee1 kinase complex with inhibitor pd352396 |
